Varicella vaccines are also called as chickenpox vaccines, which prevent the onset of chickenpox. One dose of this vaccine prevents 100% of severe disease and 95% of moderate disease. Varicella vaccine is made up of Oka strain of live attenuated virus. This vaccine is safe and constitutes rare severe side effects. Moreover, varicella vaccine is 7090% effective in preventing varicella.
The major factors that drive the growth of the global varicella vaccine, live market are rise in prevalence of chickenpox and increase in government funding on healthcare facilities. In addition, rise in drug development activities due to technological advancements in the medical sector fuels the market growth. However, high cost of vaccines restrains the market growth. Conversely, untapped economies with unmet medical needs are anticipated to provide lucrative opportunities for the market growth.
The report segments the global varicella vaccine, live market based on type, application, and geography. On the basis of type, the market is divided into monovalent and combination. In terms of application, it is categorized into chickenpox, duration of immunity, herpes zoster, and postherpetic neuralgia. Regionally, the market is analyzed in North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the market include Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Datapharm Ltd, Emergent Biosolutions, MedImmune, Inc. (parent company AstraZeneca), Sanofi A/S, CSL Limited, Valneva SE, PaxVax, Inc., and Protein Sciences Corporation.
- The study provides an in-depth analysis of the global varicella live vaccine market and the current trends and future estimations to elucidate the imminent investment pockets.
- The report presents quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on product assists to understand the trends in the industry.
- Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
Varicella Live Vaccine Market Key Segments:
- Duration of Immunity
- Herpes Zoster
- Postherpetic Neuralgia
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA